Dr. Mark Turrill practices Oncology. He graduated from Washington University School of Medicine in St. Louis. Dr. Mark Turrill is a published doctor. He published 1 publication, including: 'Phase II clinical trial of carboplatin, ifosfamide, with oral mesna for metastatic breast carcinoma.' Mark Turrill is registered with Medicare.
University of Southern California - LAC+USC Medical Center
Loma Linda University
Washington University School of Medicine in St. Louis
Sutter Lakeside Hospital| NPI NUMBER | 1568542314 | |
| NPPES Provider LastName | TURRILL | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 954535100 | |
| NPPES Provider State | CA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 2439.0 | |
| Distinct Opioid Count | 8.0 | |
| Opioid Claim Count | 328.0 | |
| Percent Opioid Claims | 13.45 |
| National Provider Identifier [NPI] | 1568542314 |
| Last Name Of The Provider | TURRILL |
| First Name Of The Provider | MARK |
| View All |
|
Dr. Thomas A. Warr, MD
This Doctor is OpenDoctor Recommended.
|